List view / Grid view
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Opdivo is the first and only Immuno-Oncology treatment proven in a Phase 3 trial to significantly extend overall survival for these patients...
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Genmab’s daratumumab (darazalex) will be investigated in a Phase III clinical study in combination with carfilzomib (kyprolis) and dexamethasone...
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
More than 75% of treatments in the Cancer Drugs Fund (CDF) which have been reappraised by the National Institute for Health and Care Excellence (NICE) have received positive recommendations for routine use in the NHS. NICE has been reappraising cancer drugs which had not been recommended in previous NICE guidance…
Linkam Scientific Instruments, announce the launch of the FDVS platform, a lyophilisation system to replicate large scale freeze drying processes...
15 November 2016 | By Niamh Louise Marriott, Digital Content Producer
We’re live at the Financial Times global pharmaceutical and biotechnology conference! Check this stream for live updates of the event…
14 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Read how the 2016 Access to Medicine Index ranks the top 20 pharmaceutical companies on their efforts to improve access to medicine in low- and middle-income countries...
11 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Prothena’s Phase 1b multiple ascending dose study of PRX002 trial found an acceptable safety and tolerability profile in patients with Parkinson’s disease...
11 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Bristol-Myers Squibb and Infinity will collaborate on a solid tumours trial to evaluate Bristol-Myers Squibb's Opdivo in combination with Infinity's...
10 November 2016 | By Broughton Software
Global pharmaceutical and biotechnology company Wockhardt has chosen the latest version of Broughton Software’s LabHQ LIMS for its new quality control laboratories in Wrexham...
10 November 2016 | By Renishaw
The new RA802 Pharmaceutical Analyser is a compact benchtop Raman imaging system, designed exclusively for the pharmaceutical industry...
10 November 2016 | By Tecan Trading AG
Tecan is making it quicker and easier than ever before for manufacturers to develop instruments for advanced liquid handling applications...
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
NICE recommends 2 cancer drugs for routine use on the NHS as part of its programme to appraise treatments that were available on the Cancer Drugs Fund...
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Mabion signed a long-term development and commercialisation agreement with Mylan Ireland a wholly owned subsidiary of Mylan N.V.
9 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Mylan and Biocon have submitted a biologics license application for MYL-1401O, a proposed biosimilar trastuzumab, to the FDA through the 351(K) pathway...
9 November 2016 | By Niamh Louise Marriott, Digital Content Producer
In this newly-created role, Dr Antonijevic will be responsible for advancing the clinical development of vasopharm’s lead ongoing program, VAS203...
